Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Autoimmune neutropenias].

T Lamy1

  • 1Service d'hématologie clinique CHU-Hôpital Pontchaillou 35033 Rennes. Thierry.Lamy@univ-rennes1.fr

La Revue Du Praticien
|January 5, 2002
PubMed
Summary
This summary is machine-generated.

Auto-immune neutropenia (AIN) is an immune disorder affecting neutrophil counts, often seen in children. Treatment advances include granulocyte-colony stimulating factor and immunosuppressive therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Large granular lymphocyte leukemia: An indolent clonal proliferative disease associated with an array of various immunologic disorders.

La Revue de medecine interne·2023
Same author

Prospect for a 60 GHz multicharged ECR ion source.

The Review of scientific instruments·2018
Same author

Soluble programmed death-ligand 1 as a prognostic biomarker for overall survival in patients with diffuse large B-cell lymphoma: a replication study and combined analysis of 508 patients.

Leukemia·2016
Same author

Pathogenesis of Autoimmune Diseases in Large Granular Lymphocyte Leukemia.

Hematology (Amsterdam, Netherlands)·2016
Same author

Inhibition of Hedgehog signaling for the treatment of lymphoma and CLL: a phase II study from the LYSA.

Annals of oncology : official journal of the European Society for Medical Oncology·2016
Same author

Status of the SPIRAL2 injector commissioning.

The Review of scientific instruments·2016
Same journal

[Prolonged fever].

La Revue du praticien·2026
Same journal

[Lower gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[Management of antiplatelet agents and oral anticoagulants in cases of gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[A history of child abuse intervention in the West].

La Revue du praticien·2026
Same journal

[Agranulocytose médicamenteuse].

La Revue du praticien·2026
Same journal

[Patient education in heart failure].

La Revue du praticien·2026
See all related articles

Area of Science:

  • Hematology
  • Immunology
  • Autoimmune Diseases

Context:

  • Auto-immune neutropenia (AIN) is a condition characterized by the immune system attacking neutrophils.
  • While often diagnosed in children, AIN can also be secondary to other autoimmune or lymphoproliferative disorders.
  • Conditions like rheumatoid arthritis, Sjogren's syndrome, and lupus erythematosus are associated with secondary AIN.

Purpose:

  • To provide an overview of auto-immune neutropenia (AIN).
  • To discuss the diagnosis and management of AIN.
  • To highlight recent therapeutic advancements.

Summary:

  • Primary AIN is common in children, while secondary AIN is linked to autoimmune diseases like rheumatoid arthritis, Sjogren's syndrome, and lupus erythematosus.
  • Diagnosis involves detecting autoantibodies against neutrophil-specific antigens (e.g., CD16).

Related Experiment Videos

  • Treatment has advanced with granulocyte-colony stimulating factor, and immunosuppressive drugs like prednisone, methotrexate, and cyclosporine A are used for severe or secondary cases.

    • Impact:

    • Granulocyte-colony stimulating factor has significantly improved AIN treatment outcomes.
    • Immunosuppressive therapies offer additional options for managing complex AIN cases.
    • Understanding AIN's associations and diagnostic markers aids in timely and effective patient care.